Table of Contents
Chapter 1. Global Animal Drug Compounding Market Executive Summary
1.1. Global Animal Drug Compounding Market Size & Forecast (2022-2032)
1.2. Regional Summary
1.3. Segmental Summary
1.3.1. By Product
1.3.2. By Animal Type
1.3.3. By Dosage Form
1.3.4. By Route of Administration
1.4. Key Trends
1.5. Recession Impact
1.6. Analyst Recommendation & Conclusion
Chapter 2. Global Animal Drug Compounding Market Definition and Research Assumptions
2.1. Research Objective
2.2. Market Definition
2.3. Research Assumptions
2.3.1. Inclusion & Exclusion
2.3.2. Limitations
2.3.3. Supply Side Analysis
2.3.3.1. Availability
2.3.3.2. Infrastructure
2.3.3.3. Regulatory Environment
2.3.3.4. Market Competition
2.3.3.5. Economic Viability (Consumer's Perspective)
2.3.4. Demand Side Analysis
2.3.4.1. Regulatory frameworks
2.3.4.2. Technological Advancements
2.3.4.3. Environmental Considerations
2.3.4.4. Consumer Awareness & Acceptance
2.4. Estimation Methodology
2.5. Years Considered for the Study
2.6. Currency Conversion Rates
Chapter 3. Global Animal Drug Compounding Market Dynamics
3.1. Market Drivers
3.1.1. Advancements in Pharmaceutical & Biotechnology Industry
3.1.2. Rising Awareness of Animal Health
3.1.3. Increased Pet Ownership
3.2. Market Challenges
3.2.1. Regulatory Constraints
3.2.2. High Costs of Compounded Medications
3.3. Market Opportunities
3.3.1. Expansion into Emerging Markets
3.3.2. Technological Innovations in Drug Compounding
Chapter 4. Global Animal Drug Compounding Market Industry Analysis
4.1. Porter's 5 Force Model
4.1.1. Bargaining Power of Suppliers
4.1.2. Bargaining Power of Buyers
4.1.3. Threat of New Entrants
4.1.4. Threat of Substitutes
4.1.5. Competitive Rivalry
4.1.6. Futuristic Approach to Porter's 5 Force Model
4.1.7. Porter's 5 Force Impact Analysis
4.2. PESTEL Analysis
4.2.1. Political
4.2.2. Economical
4.2.3. Social
4.2.4. Technological
4.2.5. Environmental
4.2.6. Legal
4.3. Top investment opportunity
4.4. Top winning strategies
4.5. Disruptive Trends
4.6. Industry Expert Perspective
4.7. Analyst Recommendation & Conclusion
Chapter 5. Global Animal Drug Compounding Market Size & Forecasts by Product 2022-2032
5.1. Segment Dashboard
5.2. Global Animal Drug Compounding Market: Product Revenue Trend Analysis, 2022 & 2032 (USD Billion)
5.2.1. Anti-infectives
5.2.2. Anti-inflammatory
5.2.3. CNS Agents
5.2.4. GI Drugs
5.2.5. Others
Chapter 6. Global Animal Drug Compounding Market Size & Forecasts by Animal Type 2022-2032
6.1. Segment Dashboard
6.2. Global Animal Drug Compounding Market: Animal Type Revenue Trend Analysis, 2022 & 2032 (USD Billion)
6.2.1. Companion Animal
6.2.1.1. Dogs
6.2.1.2. Cats
6.2.1.3. Others
6.2.2. Livestock
Chapter 7. Global Animal Drug Compounding Market Size & Forecasts by Dosage Form 2022-2032
7.1. Segment Dashboard
7.2. Global Animal Drug Compounding Market: Dosage Form Revenue Trend Analysis, 2022 & 2032 (USD Billion)
7.2.1. Capsules
7.2.2. Solutions
7.2.3. Powders
7.2.4. Suspension
7.2.5. Others
Chapter 8. Global Animal Drug Compounding Market Size & Forecasts by Route of Administration 2022-2032
8.1. Segment Dashboard
8.2. Global Animal Drug Compounding Market: Route of Administration Revenue Trend Analysis, 2022 & 2032 (USD Billion)
8.2.1. Oral
8.2.2. Injectable
8.2.3. Topical
8.2.4. Rectal
8.2.5. Ocular
Chapter 9. Global Animal Drug Compounding Market Size & Forecasts by Region 2022-2032
9.1. North America Animal Drug Compounding Market
9.1.1. U.S. Animal Drug Compounding Market
9.1.1.1. Product breakdown size & forecasts, 2022-2032
9.1.1.2. Animal Type breakdown size & forecasts, 2022-2032
9.1.1.3. Dosage Form breakdown size & forecasts, 2022-2032
9.1.1.4. Route of Administration breakdown size & forecasts, 2022-2032
9.1.2. Canada Animal Drug Compounding Market
9.1.2.1. Product breakdown size & forecasts, 2022-2032
9.1.2.2. Animal Type breakdown size & forecasts, 2022-2032
9.1.2.3. Dosage Form breakdown size & forecasts, 2022-2032
9.1.2.4. Route of Administration breakdown size & forecasts, 2022-2032
9.2. Europe Animal Drug Compounding Market
9.2.1. U.K. Animal Drug Compounding Market
9.2.2. Germany Animal Drug Compounding Market
9.2.3. France Animal Drug Compounding Market
9.2.4. Italy Animal Drug Compounding Market
9.2.5. Spain Animal Drug Compounding Market
9.2.6. Rest of Europe Animal Drug Compounding Market
9.3. Asia-Pacific Animal Drug Compounding Market
9.3.1. China Animal Drug Compounding Market
9.3.2. India Animal Drug Compounding Market
9.3.3. Japan Animal Drug Compounding Market
9.3.4. Australia Animal Drug Compounding Market
9.3.5. Rest of Asia Pacific Animal Drug Compounding Market
9.4. Latin America Animal Drug Compounding Market
9.4.1. Brazil Animal Drug Compounding Market
9.4.2. Mexico Animal Drug Compounding Market
9.4.3. Rest of Latin America Animal Drug Compounding Market
9.5. Middle East & Africa Animal Drug Compounding Market
9.5.1. Saudi Arabia Countries Animal Drug Compounding Market
9.5.2. South Africa Animal Drug Compounding Market
9.5.3. Rest of Middle East & Africa Animal Drug Compounding Market
Chapter 10. Competitive Intelligence
10.1. Key Company SWOT Analysis
10.2. Top Market Strategies
10.3. Company Profiles
10.3.1. Wedgewood Pharmacy
10.3.1.1. Key Information
10.3.1.2. Overview
10.3.1.3. Financial (Subject to Data Availability)
10.3.1.4. Product Summary
10.3.1.5. Market Strategies
10.3.2. Triangle Compounding Pharmacy
10.3.3. Davis Islands Pharmacy
10.3.4. Custom Med Compounding Pharmacy
10.3.5. Central Compounding Center South
10.3.6. Wellness Pharmacy of Cary
10.3.7. Caringbah Compounding Pharmacy
10.3.8. Millers Pharmacy
10.3.9. Smith's Pharmacy
10.3.10. Specialist Compounding Pharmacy Pte Ltd
10.3.11. Tache Pharmacy
10.3.12. Boehringer Ingelheim
10.3.13. Zoetis Inc.
10.3.14. Merck Animal Health
10.3.15. Bayer Animal Health
Chapter 11. Research Process
11.1. Research Process
11.1.1. Data Mining
11.1.2. Analysis
11.1.3. Market Estimation
11.1.4. Validation
11.1.5. Publishing
11.2. Research Attributes